NIBSC HAV HBV HCV HEV Hepatiti

NIBSC HAV HBV HCV HEV Hepatitis

Hepatitis
HAV
15/276 Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)
97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard
13/B634 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
17/B725 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1

HBV
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
07/164  Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
07/288 Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml
95/522 Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard
10/266  4th WHO International Standard for HBV DNA for NAT
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)

HCV
18/184 Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard)
14/240 British Working Standard for Anti-HCV
14/242 Anti-HCV (1 in 8 dilution)(British Working Standard)
14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification
15/B669 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1

HEV
17/B723 QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1
17/B728 QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1

Multiplex Hepatitis
14/198 HBV,HCV,HIV Multiplex

Canine Hepatitis
CHS  Anti-Canine Hepatitis Serum

NIBSC HAV HBV HCV HEV Hepatitis